Endo Yuta 遠藤雄大

Researcher Number	00868896
Affiliation (Current)	2026: 福島県立医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2026: 福島県立医科大学, 医学部, 助教 2022 – 2024: 福島県立医科大学, 医学部, 助教 2020 – 2022: 福島県立医科大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Basic Section 56040:Obstetrics and gynecology-related Except Principal Investigator Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator バイオマーカー / がん診断マーカー / 早期診断 / 自己抗体 / 卵巣がん / CLDN12 / がん / 細胞間接着 / クローディン / 細胞接着 / 子宮体癌 / 子宮頸癌 … More Except Principal Investigator … More FBWX7 / 新規治療法 / 脈管侵襲 / AURKA / FBXW７ / 子宮体癌 Less

サーフェソーム解析から同定したALPPは卵巣がんの新規診断治療標的となりうるかPrincipal Investigator
- Principal Investigator
  
  遠藤雄大
- Project Period (FY)
  2026 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Fukushima Medical University
卵巣がんにおける自己抗体の早期診断バイオマーカーとしての有用性の検証Principal Investigator
- Principal Investigator
  
  遠藤雄大
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Fukushima Medical University
子宮体癌におけるFBXW7-AURKA経路を標的とした新規治療法の開発
- Principal Investigator
  
  渡辺尚文
- Project Period (FY)
  2022 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Fukushima Medical University
Is CLDN12 a novel biomarker or a novel target for cervical cancer and endometrial cancer?Principal Investigator
- Principal Investigator
  
  Endo Yuta
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Fukushima Medical University

All 2024 2023 2022 2021 2020

All Journal Article Presentation

[Journal Article] Diaphragmatic clear cell carcinoma with Lynch syndrome after surgery for atypical endometrial hyperplasia and ovarian endometriosis: A case report.2024
- Author(s)
  Ueda M, Watanabe T, Momma T, Kanke Y, Kato A, Okabe C, Sato T, Kamo N, Endo Y, Furukawa S, Soeda S, Fujimori K
- Journal Title
  
  Mol Clin Oncol
  
  Volume: 21 Issue: 1 Pages: 46-46
- DOI
  10.3892/mco.2024.2744
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K15841
[Journal Article] Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction: A Case Report2024
- Author(s)
  Endo Y, Kamo N, Kato A, Sato T, Okabe C, Furukawa S, Watanabe T, Soeda S.
- Journal Title
  
  In Vivo
  
  Volume: 38 Issue: 2 Pages: 958-962
- DOI
  10.21873/invivo.13527
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K15841
[Journal Article] Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy2024
- Author(s)
  Endo Y, Soeda S, Yoshimoto Y, Todate Y, Hashimoto T, Furukawa S, Teranishi Y, Fujimori K.
- Journal Title
  
  J Surg Case Rep
  
  Volume: 7 Issue: 7
- DOI
  10.1093/jscr/rjae452
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K15841
[Journal Article] Claudin-9 is a novel prognostic biomarker for endometrial cancer2022
- Author(s)
  Endo Yuta、Sugimoto Kotaro、Kobayashi Makoto、Kobayashi Yasuyuki、Kojima Manabu、Furukawa Shigenori、Soeda Shu、Watanabe Takafumi、Higashi Atsuko、Higashi Tomohito、Hashimoto Yuko、Fujimori Keiya、Chiba Hideki
- Journal Title
  
  International Journal of Oncology
  
  Volume: 61 Issue: 5 Pages: 135-135
- DOI
  10.3892/ijo.2022.5425
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06950, KAKENHI-PROJECT-20K16176, KAKENHI-PROJECT-20K18224, KAKENHI-PROJECT-21K15386
[Journal Article] Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer2021
- Author(s)
  Rahman Abidur、Kobayashi Makoto、Sugimoto Kotaro、Endo Yuta、Kojima Manabu、Furukawa Shigenori、Watanabe Takafumi、Soeda Shu、Hashimoto Yuko、Fujimori Keiya、Chiba Hideki
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 22 Issue: 7 Pages: 3774-3774
- DOI
  10.3390/ijms22073774
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16176, KAKENHI-PROJECT-21K06950, KAKENHI-PROJECT-20K18224, KAKENHI-PROJECT-21K15386, KAKENHI-PROJECT-19K16615
[Journal Article] Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer2020
- Author(s)
  Kojima Manabu、Sugimoto Kotaro、Tanaka Mizuko、Endo Yuta、Kato Hitomi、Honda Tsuyoshi、Furukawa Shigenori、Nishiyama Hiroshi、Watanabe Takafumi、Soeda Shu、Fujimori Keiya、Chiba Hideki
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 10 Pages: 2748-2748
- DOI
  10.3390/cancers12102748
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16176, KAKENHI-PROJECT-20K18224, KAKENHI-PROJECT-19K16615
[Presentation] Excellent local control of proton beam therapy for recurrent epithelial ovarian cancer2024
- Author(s)
  Yuta Endo, Yuki Yoshimoto, Yoshiaki Takagawa, Motohisa Suzuki, Akiko Yamaguchi, Shu Soeda, Takafumi Watanabe , Keiya Fujimori, Masao Murakami
- Organizer
  第76回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] Proton Beam Therapy as an Effective Treatment Option for Recurrent Endometrial Cancer2024
- Author(s)
  Yuta Endo, Shu Soeda, Yuki Yoshimoto, Masanori Machida, Nor Shazrina Sulaiman, Dai Yuntao, Yoshiaki Takagawa, Yusuke Azami, Ichiro Seto, Kanako Takayama, Motohisa Suzuki, Tatsuhiko Nakasato, Ysuhiro Kikuchi, Takahiro Kato, Akiko Yamaguchi, Takafumi Watanabe, Keiya Fujimori, Masao Murakami
- Organizer
  第66回日本婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] 卵巣がんの新規抗体医薬品標的タンパク質の網羅的同定2023
- Author(s)
  瓜生開、小林信、杉本幸太郎、遠藤雄大、小林靖幸、田口歩、千葉英樹
- Organizer
  第74回日本電気泳動学会学術大会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] 卵巣癌患者腹水中に含まれる自己抗体の網羅的同定2023
- Author(s)
  小林信, 杉本幸太郎, 瓜生開, 遠藤雄大, 小島学, 小寺義男, 千葉英樹
- Organizer
  日本プロテオーム学会2023年大会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] 細胞接着分子クローディンによる卵巣がんの層別化2023
- Author(s)
  茂村碧、小林信、杉本幸太郎、遠藤雄大、小林靖幸、小島学、千葉英樹
- Organizer
  第112回日本病理学会総会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] 細胞接着分子クローディン16は卵巣癌の新規バイオマーカーである2023
- Author(s)
  茂村碧、小林信、杉本幸太郎、遠藤雄大、小林靖幸、千葉英樹
- Organizer
  第74回日本電気泳動学会学術大会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] 卵巣がん患者腹水中に含まれる自己抗体の網羅的同定2023
- Author(s)
  瓜生開、小林信、杉本幸太郎、遠藤雄大、小島学、千葉英樹
- Organizer
  第112回日本病理学会総会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] 二次元電気泳動/ウエスタンブロット法によるがん患者由来自己抗体の新規網羅的同定法2023
- Author(s)
  瓜生開、小林信、杉本幸太郎、遠藤雄大、小林靖幸、田口歩、千葉英樹
- Organizer
  第74回日本電気泳動学会学術大会
- Data Source
  KAKENHI-PROJECT-23K15841
[Presentation] Claudin-9 is a novel biomarker of the prognosis of Endometrial cancer2022
- Author(s)
  Yuta Endo, Shu Soeda, Tetsu Sato, Chikako Okabe, Makiko Ueda, Norihito Kamo, Manabu Kojima, Shigeori Furukawa, Takafumi Watanabe, Keiya Fujimori
- Organizer
  第74回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-20K18224
[Presentation] Claudin-9は子宮体がんの新規予後マーカーである2021
- Author(s)
  遠藤雄大,杉本幸太郎,Abidur Rahman,小林信,千葉英樹
- Organizer
  第72回日本電気泳動学会総会
- Data Source
  KAKENHI-PROJECT-20K18224
[Presentation] Claudin-9は子宮内膜癌の予後不良因子である2021
- Author(s)
  遠藤雄大、杉本幸太郎、小林信、藤森敬也、千葉英樹
- Organizer
  第111回日本病理学会総会
- Data Source
  KAKENHI-PROJECT-20K18224

1. 渡辺尚文 (80347228)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 古川茂宜 (30566815)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 小林信

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 杉本幸太郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 小島学

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

Endo Yuta 遠藤 雄大

Research Projects

Research Products

Co-Researchers

サーフェソーム解析から同定したALPPは卵巣がんの新規診断治療標的となりうるかPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

卵巣がんにおける自己抗体の早期診断バイオマーカーとしての有用性の検証Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

子宮体癌におけるFBXW7-AURKA経路を標的とした新規治療法の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Is CLDN12 a novel biomarker or a novel target for cervical cancer and endometrial cancer?Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Diaphragmatic clear cell carcinoma with Lynch syndrome after surgery for atypical endometrial hyperplasia and ovarian endometriosis: A case report.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction: A Case Report2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Claudin-9 is a novel prognostic biomarker for endometrial cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] Excellent local control of proton beam therapy for recurrent epithelial ovarian cancer2024

Author(s)

Organizer

Data Source

[Presentation] Proton Beam Therapy as an Effective Treatment Option for Recurrent Endometrial Cancer2024

Author(s)

Organizer

Data Source

[Presentation] 卵巣がんの新規抗体医薬品標的タンパク質の網羅的同定2023

Author(s)

Organizer

Data Source

[Presentation] 卵巣癌患者腹水中に含まれる自己抗体の網羅的同定2023

Author(s)

Organizer

Data Source

[Presentation] 細胞接着分子クローディンによる卵巣がんの層別化2023

Author(s)

Organizer

Data Source

[Presentation] 細胞接着分子クローディン16は卵巣癌の新規バイオマーカーである2023

Author(s)

Endo Yuta 遠藤雄大